Primary Site >> Colorectal Cancer
Gene >> AKR1B10
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. PMID: 17597105 |
Ref: Fibrates in the chemical action of daunorubicin. PMID: 19442055 Ref: Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib. PMID: 19567817 Ref: Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. PMID: 19643728 |
Ref: [Downregulation of AKR1B10 gene expression in colorectal cancer]. PMID: 20586184 Ref: Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10. PMID: 21087085 |
Ref: Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. PMID: 21215737 Ref: Involvement of the aldo-keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms. PMID: 21317765 Ref: Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid. PMID: 21561086 |
Ref: Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers. PMID: 22319498 |
Ref: AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis. PMID: 24140838 |
Ref: Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer. PMID: 24599561 Ref: A mechanically-induced colon cancer cell population shows increased metastatic potential. PMID: 24884630 Ref: Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. PMID: 25120755 |
Ref: Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. PMID: 25538260 Ref: Detection of AKR1B10 in Peripheral Blood by Anti-AKR1B10-Conjugated CdTe/CdS Quantum Dots. PMID: 26554246 |
Ref: Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-gamma-dependent mechanism. PMID: 27417252 Ref: Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study. PMID: 27490803 |
Ref: Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds. PMID: 26969882 Ref: Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. PMID: 28929377 |
Ref: AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells. PMID: 29846015 |